A drug that’s already approved to treat certain ovarian cancers holds some advanced breast cancers at bay longer than standard chemotherapy.
Offering abiraterone (Zytiga) up-front with standard hormone treatment extends survival in men whose prostate cancer has spread.
Adding abiraterone to hormone therapy at the start of treatment for prostate cancer improves survival by 37 per cent.
We speak to Jane Hair, a biobanker involved in the National Lung Matrix Trial, about what her job involves.
We speak to Amanda Watson, research nurse on the National Lung Matrix Trial, about what her job involves.
We speak to Susie Brown, Trial Coordinator on the National Lung Matrix Trial, about what her job involves.
We speak to Cindy Billingham, lead statistician on the National Lung Matrix Trial, about what her job involves.
Study finds that young adults in the US who hadn’t been vaccinated were around 14 times more likely to have oral HPV infections than those who were vaccinated.
Our research has led to new clinical trials testing a combination of hormone therapies in women with early, double-positive breast cancer.
A researcher explains an early stage clinical trial testing the potential of a new type of immunotherapy to treat neuroblastoma.